165 related articles for article (PubMed ID: 16917230)
1. Impact of inflammation on the duodenal mRNA expression of CYP3A and P-glycoprotein in children with Crohn's disease.
Fakhoury M; Lecordier J; Medard Y; Peuchmaur M; Jacqz-Agrain E
Inflamm Bowel Dis; 2006 Aug; 12(8):745-9. PubMed ID: 16917230
[TBL] [Abstract][Full Text] [Related]
2. Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age.
Fakhoury M; Litalien C; Medard Y; Cavé H; Ezzahir N; Peuchmaur M; Jacqz-Aigrain E
Drug Metab Dispos; 2005 Nov; 33(11):1603-7. PubMed ID: 16049125
[TBL] [Abstract][Full Text] [Related]
3. Crohn's Disease Is Associated with Decreased CYP3A4 and P-Glycoprotein Protein Expression.
Wilson A; Urquhart BL; Ponich T; Chande N; Gregor JC; Beaton M; Kim RB
Mol Pharm; 2019 Sep; 16(9):4059-4064. PubMed ID: 31393129
[TBL] [Abstract][Full Text] [Related]
4. Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum.
Canaparo R; Finnström N; Serpe L; Nordmark A; Muntoni E; Eandi M; Rane A; Zara GP
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1138-44. PubMed ID: 17880367
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
[TBL] [Abstract][Full Text] [Related]
6. Expression of cytochromes P450 3A and P-glycoprotein in human large intestine in paired tumour and normal samples.
Canaparo R; Nordmark A; Finnström N; Lundgren S; Seidegård J; Jeppsson B; Edwards RJ; Boobis AR; Rane A
Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):240-8. PubMed ID: 17371528
[TBL] [Abstract][Full Text] [Related]
7. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas.
Nakamura T; Sakaeda T; Ohmoto N; Tamura T; Aoyama N; Shirakawa T; Kamigaki T; Nakamura T; Kim KI; Kim SR; Kuroda Y; Matsuo M; Kasuga M; Okumura K
Drug Metab Dispos; 2002 Jan; 30(1):4-6. PubMed ID: 11744604
[TBL] [Abstract][Full Text] [Related]
8. Decreased Pregnane X Receptor Expression in Children with Active Crohn's Disease.
Shakhnovich V; Vyhlidal C; Friesen C; Hildreth A; Singh V; Daniel J; Kearns GL; Leeder JS
Drug Metab Dispos; 2016 Jul; 44(7):1066-9. PubMed ID: 27013401
[TBL] [Abstract][Full Text] [Related]
9. Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression?
Paine MF; Ludington SS; Chen ML; Stewart PW; Huang SM; Watkins PB
Drug Metab Dispos; 2005 Mar; 33(3):426-33. PubMed ID: 15608139
[TBL] [Abstract][Full Text] [Related]
10. Effects of Curcuma extracts and curcuminoids on expression of P-glycoprotein and cytochrome P450 3A4 in the intestinal cell culture model LS180.
Graber-Maier A; Büter KB; Aeschlimann J; Bittel C; Kreuter M; Drewe J; Gutmann H
Planta Med; 2010 Nov; 76(16):1866-70. PubMed ID: 20509107
[TBL] [Abstract][Full Text] [Related]
11. Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course.
Zhang H; Wu X; Wang H; Mikheev AM; Mao Q; Unadkat JD
Mol Pharmacol; 2008 Sep; 74(3):714-23. PubMed ID: 18509067
[TBL] [Abstract][Full Text] [Related]
12. Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.
Alrubia S; Mao J; Chen Y; Barber J; Rostami-Hodjegan A
Clin Pharmacokinet; 2022 Oct; 61(10):1365-1392. PubMed ID: 36056298
[TBL] [Abstract][Full Text] [Related]
13. Effect of Crohn's Disease on Villous Length and CYP3A4 Expression in the Pediatric Small Intestine.
Vyhlidal CA; Chapron BD; Ahmed A; Singh V; Casini R; Shakhnovich V
Clin Transl Sci; 2021 Mar; 14(2):729-736. PubMed ID: 33278326
[TBL] [Abstract][Full Text] [Related]
14. CYP3A4 Activity is Markedly Lower in Patients with Crohn's Disease.
Wilson A; Tirona RG; Kim RB
Inflamm Bowel Dis; 2017 May; 23(5):804-813. PubMed ID: 28301431
[TBL] [Abstract][Full Text] [Related]
15. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
[TBL] [Abstract][Full Text] [Related]
16. Modulation of expression/function of intestinal P-glycoprotein under disease states.
Murakami T; Bodor E; Bodor N
Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):59-78. PubMed ID: 31821048
[No Abstract] [Full Text] [Related]
17. Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells.
Fan J; Maeng HJ; Du Y; Kwan D; Pang KS
Eur J Pharm Sci; 2011 Jan; 42(1-2):19-29. PubMed ID: 20955791
[TBL] [Abstract][Full Text] [Related]
18. Decreased intestinal CYP3A and P-glycoprotein activities in rats with adjuvant arthritis.
Uno S; Kawase A; Tsuji A; Tanino T; Iwaki M
Drug Metab Pharmacokinet; 2007 Aug; 22(4):313-21. PubMed ID: 17827786
[TBL] [Abstract][Full Text] [Related]
19. A study of intestinal absorption of bicyclol in rats: active efflux transport and metabolism as causes of its poor bioavailability.
Tan W; Chen H; Zhao J; Hu J; Li Y
J Pharm Pharm Sci; 2008; 11(3):97-105. PubMed ID: 18801310
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea.
Jun KR; Lee W; Jang MS; Chun S; Song GW; Park KT; Lee SG; Han DJ; Kang C; Cho DY; Kim JQ; Min WK
Transplantation; 2009 Apr; 87(8):1225-31. PubMed ID: 19384171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
